Articles with "wave adalimumab" as a keyword



Photo by bagasvg from unsplash

Riding the Wave of Adalimumab Biosimilars: Considerations for Pediatric Gastroenterologists

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Pediatric Gastroenterology and Nutrition"

DOI: 10.1097/mpg.0000000000003757

Abstract: In January of 2023, the first adalimumab biosimilar became available in the United States for treatment of inflammatory bowel disease (IBD). Seven more adalimumab biosimilars are set to become available over the summer and fall… read more here.

Keywords: biosimilars considerations; considerations pediatric; wave adalimumab; riding wave ... See more keywords